See up to 3 months of NEOG. The 7-day demo opens the 1M and 3M ranges and puts NEOG on your watchlist.
Start 7-day demoLatest NEOG insider trades
About NEOGEN CORP (NEOG)
The SEC lists NEOGEN CORP under CIK 0000711377, in in vitro and in vivo diagnostic substances. We track it alongside the rest of the Health Care sector.
NEOG Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 875 | $10K |
| Grant or award | 26 | 1,836,192 | |
| Tax withholding / forfeiture | 2 | 22,762 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NEOG insider transactions (Form 4)
68115 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Edward Adent - Officer | Option exercise | Common Stock | 32,936 | $5.63 | $185K | |
| John Edward Adent - Officer | Tax withholding / forfeiture | Common Stock | 9,297 | $5.63 | $52K | |
| John Edward Adent - Officer | Option exercise | Restricted Stock Units | 32,936 | $5.63 | $185K | |
 Ronald D. Green - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Ronald D. Green - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| James C. Borel - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| James C. Borel - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
 Jeffrey D. Capello - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Jeffrey D. Capello - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
 William T. Boehm - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| William T. Boehm - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
 Rafael A. Rodriguez - Director | Option exercise | Common Stock | 2,071 | $5.63 | $12K | |
| Rafael A. Rodriguez - Director | Option exercise | Restricted Stock Units | 2,071 | $5.63 | $12K | |
| John Patrick Moylan - Officer | Option exercise | Common Stock | 1,985 | $5.43 | $11K | |
| John Patrick Moylan - Officer | Tax withholding / forfeiture | Common Stock | 593 | $5.43 | $3K | |
| John Patrick Moylan - Officer | Option exercise | Restricted Stock Units | 1,985 | $5.43 | $11K | |
 Amy M. Rocklin - Officer | Option exercise | Common Stock | 10,324 | $5.43 | $56K | |
| Amy M. Rocklin - Officer | Tax withholding / forfeiture | Common Stock | 3,005 | $5.43 | $16K | |
| Amy M. Rocklin - Officer | Option exercise | Restricted Stock Units | 10,324 | $5.43 | $56K | |
 Douglas Edward Jones - Officer | Option exercise | Common Stock | 14,294 | $5.43 | $78K | |
| Douglas Edward Jones - Officer | Tax withholding / forfeiture | Common Stock | 4,160 | $5.43 | $23K | |
| Douglas Edward Jones - Officer | Option exercise | Restricted Stock Units | 14,294 | $5.43 | $78K | |
| David H. Naemura - Officer | Option exercise | Common Stock | 14,294 | $5.43 | $78K | |
| David H. Naemura - Officer | Tax withholding / forfeiture | Common Stock | 5,947 | $5.43 | $32K | |
| David H. Naemura - Officer | Option exercise | Restricted Stock Units | 14,294 | $5.43 | $78K | |
| John Edward Adent - Officer | Option exercise | Common Stock | 35,736 | $5.43 | $194K | |
| John Edward Adent - Officer | Option exercise | Restricted Stock Units | 35,736 | $5.43 | $194K | |
| Mikheal Nassif - Officer | Grant or award | Common Stock | 184,162 | $5.43 | $1.00M | |
| Mikheal Nassif - Officer | Grant or award | Common Stock | 414,365 | $5.43 | $2.25M | |
| Mikheal Nassif - Officer | Grant or award | Common Stock (Right to Buy) | 1,065,042 | $0.00 | - | |
| Mikheal Nassif - Officer | Grant or award | Common Stock (Right to Buy) | 473,352 | $0.00 | - | |
| John Patrick Moylan - Officer | Grant or award | Common Stock | 18,416 | $5.43 | $100K | |
| John Patrick Moylan - Officer | Grant or award | Common Stock (Right to Buy) | 47,336 | $0.00 | - | |
| Amy M. Rocklin - Officer | Grant or award | Common Stock | 119,705 | $5.43 | $650K | |
| Amy M. Rocklin - Officer | Grant or award | Common Stock (Right to Buy) | 307,680 | $0.00 | - | |
| David H. Naemura - Officer | Grant or award | Common Stock | 230,203 | $5.43 | $1.25M | |
| David H. Naemura - Officer | Grant or award | Common Stock (Right to Buy) | 591,690 | $0.00 | - | |
| William T. Boehm - Director | Open-market purchase | Common Stock | 5,000 | $5.24 | $26K | |
| James C. Borel - Director | Open-market purchase | Common Stock | 35,000 | $4.89 | $171K | |
| Jeffrey D. Capello - Director | Open-market purchase | Common Stock | 20,712 | $4.84 | $100K | |
| Rafael A. Rodriguez - Director | Open-market purchase | Common Stock | 7,474 | $4.59 | $34K | |
| David H. Naemura - Officer | Option exercise | Common Stock | 12,911 | $14.14 | $183K | |
| David H. Naemura - Officer | Tax withholding / forfeiture | Common Stock | 5,371 | $14.14 | $76K | |
| David H. Naemura - Officer | Option exercise | Restricted Stock Units | 12,911 | $14.14 | $183K | |
| Thierry Bernard - Director | Grant or award | Restricted Stock Units | 5,620 | $14.44 | $81K | |
| Thierry Bernard - Director | Grant or award | Common Stock (Right to Buy) | 17,207 | $0.00 | - | |
| Amy M. Rocklin - Officer | Option exercise | Common Stock | 9,475 | $13.81 | $131K | |
| Amy M. Rocklin - Officer | Tax withholding / forfeiture | Common Stock | 2,758 | $13.81 | $38K | |
| Amy M. Rocklin - Officer | Option exercise | Restricted Stock Units | 9,475 | $13.81 | $131K | |
 Aashima Gupta - Director | Option exercise | Common Stock | 1,776 | $13.81 | $25K | |
| Aashima Gupta - Director | Option exercise | Restricted Stock Units | 1,776 | $13.81 | $25K | |
| Douglas Edward Jones - Officer | Option exercise | Common Stock | 15,504 | $13.81 | $214K | |
| Douglas Edward Jones - Officer | Tax withholding / forfeiture | Common Stock | 4,512 | $13.81 | $62K | |
| Douglas Edward Jones - Officer | Option exercise | Restricted Stock Units | 15,504 | $13.81 | $214K | |
 Catherine E. Woteki - Director | Option exercise | Common Stock | 1,776 | $13.81 | $25K | |
| Catherine E. Woteki - Director | Option exercise | Restricted Stock Units | 1,776 | $13.81 | $25K | |
| David H. Naemura - Officer | Option exercise | Common Stock | 15,504 | $13.81 | $214K | |
| David H. Naemura - Officer | Tax withholding / forfeiture | Common Stock | 6,450 | $13.81 | $89K | |
| David H. Naemura - Officer | Option exercise | Restricted Stock Units | 15,504 | $13.81 | $214K | |
 James P. Tobin - Director | Option exercise | Common Stock | 1,776 | $13.81 | $25K | |
| James P. Tobin - Director | Option exercise | Restricted Stock Units | 1,776 | $13.81 | $25K | |
| John Edward Adent - Officer | Option exercise | Common Stock | 38,760 | $13.81 | $535K | |
| John Edward Adent - Officer | Tax withholding / forfeiture | Common Stock | 11,280 | $13.81 | $156K | |
| John Edward Adent - Officer | Option exercise | Restricted Stock Units | 38,760 | $13.81 | $535K | |
| Ronald D. Green - Director | Option exercise | Common Stock | 1,776 | $13.81 | $25K | |
| Ronald D. Green - Director | Option exercise | Restricted Stock Units | 1,776 | $13.81 | $25K | |
| James C. Borel - Director | Option exercise | Common Stock | 1,776 | $13.81 | $25K | |
| James C. Borel - Director | Option exercise | Restricted Stock Units | 1,776 | $13.81 | $25K |
See every NEOG filing on record
These pages show the latest 90 of 115 Form 4 filings on record. The 7-day demo shows all 115, and sign-up brings you back to this table.
Item 5.07, 9.01
Item 2.02, 9.01
Item 5.02
Item 2.02, 9.01
Recent NEOG Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
NEOG insider trading FAQ
What is the latest insider trade for NEOG?
NEOGEN CORP (NEOG) had 17 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for NEOG runs to 115 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NEOG stock?
2 insider purchases of NEOG were filed in the last 90 days, totaling $10K.
How many insiders are selling NEOG stock?
No insider sales of NEOG were filed in the last 90 days.
Where can I see NEOG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NEOG Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mikheal Nassif view on EDGAR
- - Catherine E. Woteki view on EDGAR
- - Andrea F. Wainer view on EDGAR
- - Rafael A. Rodriguez view on EDGAR
- - Avi Pelossof view on EDGAR
- - Aashima Gupta view on EDGAR
- - Ronald D. Green view on EDGAR
- - Jeffrey D. Capello view on EDGAR
- - James C. Borel view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NEOG's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NEOG with a 7-day demo
- NEOG on your watchlist
- Every NEOG Form 4 filing on record
- Up to 3 months of NEOG price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
